Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Can My Medication Cause Chronic Fatigue?; polyDNA Recommends Gene-Eden-VIR Against Physical and Mental Fatigue
  • USA - English


News provided by

PolyDNA

Apr 10, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX


Many medications actually harm the immune system. This weakening of the immune system can allow an infection with a latent virus, such as with EBV, to create conditions favorable to viral reactivation and to feelings of fatigue. - polyDNA

Post this

Rochester, NY (PRWEB) April 10, 2014 -- polyDNA’s most recent survey, taken in April 2014, showed that many respondents wanted to know if their medications could cause chronic fatigue. There are many causes of chronic fatigue; however research shows that side effects of most drugs include feelings of physical and mental fatigue. (See the AARP, from June 12, 2012) (1). polyDNA recommends that individuals who experience chronic fatigue talk to their doctors about Gene-Eden-VIR. This natural product was recently shown to reduce symptoms of physical and mental fatigue in a post-marketing clinical study that followed FDA guidelines.

What medications can cause fatigue?

There are many. They include blood pressure drugs, statins (a class of drugs used to lower cholesterol levels) and fibrates (drugs that treat metabolic disorders), proton pump inhibitors (drugs whose main action is a pronounced and long-lasting reduction of gastric acid production), benzodiazepines (tranquilizers), antihistamines, antidepressants, antipsychotics, and more (1). Individuals can check if their medication causes fatigue by inserting the name of the drug in the search bar located here: http://www.drugs.com.

How do these drugs cause chronic fatigue?

These drugs weaken the immune system. As a result, according to Dr. Hanan Polansky’s theory of Microcompetition, the decrease in the immune system will increase the number of latent viruses in these patients. One typical virus that infects most people is the Epstein Barr Virus (EBV). Research shows that in high concentrations, these viruses cause fatigue. Therefore, polyDNA suggests reducing the numbers of latent viruses in the body to reduce physical and mental fatigue. Individuals can read more about Dr. Polansky’s theory here: http://www.cbcd.net.

How do these drugs weaken the immune system?

The drug classes mentioned above can depress the central nervous system, or they may deplete vitamins and minerals that the body uses for producing energy. They also can interfere with the activity of immune cells. For example, a blood pressure drug called leflunomide, (brand name Arava) specifically “reduces inflammation by suppressing the activity of immune cells.” (See Medicinenet.com, last reviewed April 23, 2012) (2). Suppressing the immune system can lead to a reactivation of latent viruses in the body. In addition to blood pressure drugs that lower the immune system, a study found that “Statins are widely used lipid-lowering drugs with immunomodulatory properties that may favour reactivation of latent…virus infection.” (See the journal Clinical Infectious Diseases, from November 13, 2013) (3). Proton pump inhibitors can suppress the immune system too. Another study showed that “proton pump inhibitors appear to favor immune suppression.” (See the journal BMC Medicine, from June 7, 2012) (4). The list goes on and on.

“Studies associate the feeling of fatigue with a sense of tiredness, lack of energy, a feeling of exhaustion, and impaired physical and/or cognitive performance.” (See Pharmacology & Pharmacy, from March 2014) (5).

Many medications actually harm the immune system. This weakening of the immune system can allow an infection with a latent virus, such as with EBV, to create conditions favorable to viral reactivation and to feelings of fatigue. In fact, the virus itself is responsible for feelings of “extreme fatigue.” (See the CDC, last updated January 7, 2014) (6).

polyDNA recommends that individuals who take prescription drugs ask their doctors for a blood test that identifies the existence of a latent infection with EBV or CMV (human cytomegalovirus), two of the most common latent viruses. If positive, that individual should then speak to their doctors about Gene-Eden-VIR. This natural antiviral targets the latent EBV and CMV, and was recently proven to reduce mental and physical fatigue in a post-marketing clinical study that followed FDA guidelines (5).

This is the second time that a peer reviewed medical journal published a paper reporting a clinical study on Gene-Eden-VIR’s, patent protected, natural formula. The first paper, entitled “Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study” was published in September 2013 and can be found at:http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101#.UzQEv6iSz90.

To view the entire paper on Gene-Eden-VIR and fatigue, visit: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=44234#.UzQC5KiSz90.

For more information on Gene-Eden-VIR, please visit the product’s official website at: http://www.gene-eden-vir.com.

We invite the media to contact us for interviews at: note (AT) buy-gene-eden.com or phone 585-250-9999. All orders of Gene-Eden-VIR are completely confidential, and no information is shared or sold to any third party. Privacy is assured.

References:

(1) 9 Types of Medications That Can Lead to Chronic Fatigue. Published on June 12, 2012.
http://www.aarp.org/health/drugs-supplements/info-06-2012/medications-that-cause-chronic-fatigue.3.html

(2) Medicinenet.com - leflunomide, Arava. Last reviewed on April 23, 2012.
http://www.medicinenet.com/leflunomide/article.htm

(3) Statins and the risk of herpes zoster: a population-based cohort study. Published November 13, 2013
http://www.ncbi.nlm.nih.gov/pubmed/24235264

(4) Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis. Published on June 7, 2012.
http://www.biomedcentral.com/1741-7015/10/57

(5) Gene-Eden-VIR Decreased Physical and Mental Fatigue in a Post Marketing Clinical Study That Followed FDA Guidelines; Results Support Microcompetition Theory. Published in March 2014.
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=44234#.UzfrpqiSz90

(6) CDC - Epstein-Barr Virus and Infectious Mononucleosis.
http://www.cdc.gov/epstein-barr/

polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.

polyDNA developed Gene-Eden-VIR, an antiviral natural remedy that helps the immune system kill latent viruses.

Mike Davis, PolyDNA, http://gene-eden-kill-virus.com/, +1 5852509999, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.